Binder jetting 3D printing in fabricating pharmaceutical solid products for precision medicine
Basic & Clinical Pharmacology & Toxicology · 2024-03 · 134 (3) · 325-332
DOI: 10.1111/bcpt.13974 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, online erschienen am 19.01.2024. Verfasst von Yingya Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Technology, Pharmaceutical, Precision Medicine. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Mille International A/S, Roskilde, Denmark.
Abstract (Originalsprache)
Current treatment strategies are moving towards patient‐centricity, which emphasizes the need for new solutions allowing for medication tailored to a patient. This can be realized by precision medicine where patient diversity is considered during treatment. However, the broader use of precision medicine is restricted by the current technological solutions and rigid manufacturing of pharmaceutical products by mass production principles. Additive manufacturing of pharmaceutical products can provide a feasible solution to this challenge. In this review, a particular subtype of additive manufacturing, that is, binder jetting 3D printing, is introduced as a solution for fabricating pharmaceutical solid products that can be considered as precision medicine. Technical aspects, practical applications, unique advantages and challenges related to this technique are discussed, indicating that binder jetting 3D printing possesses the potential for fabricating already new product prototypes, where diversity in patient treatment in terms of the needs for specific drug type, dose and drug release can be accounted. To further advance this type of mass customization of pharmaceuticals, multidisciplinary research initiatives are needed not only to cover the engineering aspects but also to bridge these innovations with patient‐centric perspectives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Novo Nordisk A/S, Bagsvaerd, Denmark.
Förderung
- Mille International A/S, Roskilde, Denmark
Zitieren
APA
Wang, Y., Genina, N., Müllertz, A., & Rantanen, J. (2024). Binder jetting 3D printing in fabricating pharmaceutical solid products for precision medicine. Basic & Clinical Pharmacology & Toxicology, 134(3), 325-332. https://doi.org/10.1111/bcpt.13974
Vancouver
Wang Y, Genina N, Müllertz A, Rantanen J. Binder jetting 3D printing in fabricating pharmaceutical solid products for precision medicine. Basic & Clinical Pharmacology & Toxicology. 2024;134(3):325-332. doi:10.1111/bcpt.13974
BibTeX
@article{Wang2024,
author = {Wang, Yingya and Genina, Natalja and Müllertz, Anette and Rantanen, Jukka},
title = {Binder jetting 3D printing in fabricating pharmaceutical solid products for precision medicine},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2024},
volume = {134},
number = {3},
pages = {325--332},
doi = {10.1111/bcpt.13974}
}
EUVIMED